FDA Floats Plan For Measuring Drugmaker Quality
The U.S. Food and Drug Administration on Monday described manufacturing data that it intends to collect from drugmakers in order to measure quality, with the results helping to identify low-performing production...To view the full article, register now.
Already a subscriber? Click here to view full article